Macromolecular neuraminidase-binding compounds
US6680054B1 · kind B1 · utility
50Cited by
4References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 16, 1999 |
| Grant date | Jan 20, 2004 |
| Priority date | — |
| Expiry date | Jul 16, 2019 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/924
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides novel macromolecules, methods for their preparation, pharmaceutical formulations thereof and their use as anti-influenza agents. The invention also provides a novel diagnostic method which can be used for detection of all types of influenza A and B virus. The macromolecular compound of the invention has attached to it one or more molecules (neuraminidase binders) which bind to the active site of influenza virus neuraminidase but which are not cleaved by the neuraminidase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.